TEMPLE, Texas — Actress Kelley Mack, best known for her roles on "The Walking Dead" and "Chicago Med," died Saturday at 33 years old after a lengthy battle with a rare disease. Mack's family reports ...
Credit: Jazz Pharmaceuticals. Modeyso is the first FDA-approved treatment for this rare brain tumor. Continued approval for this indication is contingent upon verification of clinical benefit in the ...
DUBLIN, Aug. 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso™ ...
Another intriguing discovery emerged during the study. The researchers found that the combined treatment activated signals ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved Modeyso for patients with H3 K27M-mutant diffuse midline glioma. The therapy showed an overall ...
Diffuse midline glioma (DMG), H3K27-altered, is a lethal pediatric high-grade tumor, lacking effective treatment options, primarily depending on clinical trials. Epigenetic agent-based immunotherapy ...
Kelley Mack, the actress best known for her role in "The Walking Dead" TV series, has died. Mack, 33, died of an aggressive glioma, or tumor, that attacked her central nervous system. Kelley Mack, the ...
Modeyso is the first and only treatment option approved by the FDA for this ultra-rare and aggressive brain tumor that affects an estimated 2,000 people in the U.S. each year, many of whom are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results